Although not in PCa, several studies have combined POLQ inhibitors with DNA-PKcs inhibitors and observed the increased killing of p53-deficient cells, as well as enhanced radiosensitivity [256,257]. The gene discussed is PRKDC; the disease is posterior cortical atrophy.